PUBLISHER: Allied Market Research | PRODUCT CODE: 1566956
PUBLISHER: Allied Market Research | PRODUCT CODE: 1566956
Alcohol Dehydrogenase Market By Type (Medium-chain Enzymes, Short-chain Enzymes) , By Application (Alcohol Concentration Detection, Disease Diagnosis, Catalyst) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The alcohol dehydrogenase market was valued at $0.6 billion in 2023, and is projected to reach $1.1 billion by 2033, growing at a CAGR of 6.5% from 2024 to 2033.
Alcohol dehydrogenase is class of zinc-containing enzyme that is majorly responsible for the oxidation of alcohols to aldehydes or ketones. This enzyme is predominantly synthesized liver and stomach of humans that acts as a primary defense against a toxic molecule, alcohol. Alcohol dehydrogenase detoxifies this potentially harmful molecule into a mere foodstuff, thereby playing a critical role in preventing the accumulation of toxic levels and eliminating alcohol from the body.
The growth of the global alcohol dehydrogenase market is majorly driven by rise in global alcohol consumption and alarming increase in prevalence of alcohol-related diseases. This is attributed to the fact that alcohol dehydrogenase mitigates the intoxicating effects of alcohol and facilitates its excretion from the body. According to the World Health Organization, alcohol is an established carcinogen and is known to increase the risk of cancer. Approximately 401,000 cancer deaths were registered in 2019 due to alcohol consumption. In addition, rise in awareness about alcohol-related health issues and the need for effective diagnostic tools and treatments boosts the demand for alcohol dehydrogenase. Moreover, increase in adoption of alcohol dehydrogenase in green chemistry notably contributes toward the growth of the market. However, high production cost of alcohol dehydrogenase restrains the growth of the market. Furthermore, the complexity associated with the production process and the need for advanced technology and skilled technicians incur additional costs, which further restrict the market growth. On the contrary, advances in diagnostic technologies, such as more accurate and efficient assays for measuring alcohol dehydrogenase activity, are expected to offer remunerative opportunities for the market growth during the forecast period. Furthermore, technological innovations in biotechnology and enzyme engineering contribute to the development of new alcohol dehydrogenase products and applications, including recombinant alcohol dehydrogenase enzymes and improved diagnostic assays, which are anticipated to open new avenues for the expansion of the market.
The alcohol dehydrogenase industry is segmented into type, application, and region. On the basis of type, the market is bifurcated into medium-chain enzymes and short-chain enzymes. On the basis of application, the market is segregated into alcohol concentration detection, disease diagnosis, and catalyst. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the medium-chain segment dominated the market in 2023.
On the basis of application, the alcohol concentration detection segment held a major share of the market in 2023.
Region wise, North America exhibited the highest growth in 2023.
Competition Analysis
Competitive analysis and profiles of the major players in the global alcohol dehydrogenase market include Sigma-Aldrich, Thermo Fisher Scientific, BioVision Inc., Creative Enzymes Technologies, LLC, MP Biomedicals, Randox Laboratories Limited, Sekisui Diagnostics, Prospec-Tany Technogene Ltd., Roche Diagnostics, and Worthington Biochemical Corporation These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Historic market data
- Reimbursement Scenario
Key Market Segments
By Type
- Medium-chain Enzymes
- Short-chain Enzymes
By Application
- Alcohol Concentration Detection
- Disease Diagnosis
- Catalyst
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
Key Market Players:
- Sigma-Aldrich
- Thermo Fisher Scientific Inc.
- BioVision Inc.
- Creative Enzymes Technologies, LLC
- MP Biomedicals
- Randox Laboratories Limited
- Sekisui Diagnostics
- Prospec-Tany Technogene Ltd.
- Roche Diagnostics
- Worthington Biochemical Corp.
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
CHAPTER 4: ALCOHOL DEHYDROGENASE MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Medium-chain Enzymes
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Short-chain Enzymes
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
CHAPTER 5: ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Alcohol Concentration Detection
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Disease Diagnosis
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Catalyst
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
CHAPTER 6: ALCOHOL DEHYDROGENASE MARKET, BY REGION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
- 6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Type
- 6.2.3. Market Size and Forecast, By Application
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Alcohol Dehydrogenase Market
- 6.2.5.1. Market Size and Forecast, By Type
- 6.2.5.2. Market Size and Forecast, By Application
- 6.2.6. Canada Alcohol Dehydrogenase Market
- 6.2.6.1. Market Size and Forecast, By Type
- 6.2.6.2. Market Size and Forecast, By Application
- 6.2.7. Mexico Alcohol Dehydrogenase Market
- 6.2.7.1. Market Size and Forecast, By Type
- 6.2.7.2. Market Size and Forecast, By Application
- 6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Type
- 6.3.3. Market Size and Forecast, By Application
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. France Alcohol Dehydrogenase Market
- 6.3.5.1. Market Size and Forecast, By Type
- 6.3.5.2. Market Size and Forecast, By Application
- 6.3.6. Germany Alcohol Dehydrogenase Market
- 6.3.6.1. Market Size and Forecast, By Type
- 6.3.6.2. Market Size and Forecast, By Application
- 6.3.7. Italy Alcohol Dehydrogenase Market
- 6.3.7.1. Market Size and Forecast, By Type
- 6.3.7.2. Market Size and Forecast, By Application
- 6.3.8. Spain Alcohol Dehydrogenase Market
- 6.3.8.1. Market Size and Forecast, By Type
- 6.3.8.2. Market Size and Forecast, By Application
- 6.3.9. UK Alcohol Dehydrogenase Market
- 6.3.9.1. Market Size and Forecast, By Type
- 6.3.9.2. Market Size and Forecast, By Application
- 6.3.10. Rest of Europe Alcohol Dehydrogenase Market
- 6.3.10.1. Market Size and Forecast, By Type
- 6.3.10.2. Market Size and Forecast, By Application
- 6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Type
- 6.4.3. Market Size and Forecast, By Application
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. China Alcohol Dehydrogenase Market
- 6.4.5.1. Market Size and Forecast, By Type
- 6.4.5.2. Market Size and Forecast, By Application
- 6.4.6. Japan Alcohol Dehydrogenase Market
- 6.4.6.1. Market Size and Forecast, By Type
- 6.4.6.2. Market Size and Forecast, By Application
- 6.4.7. India Alcohol Dehydrogenase Market
- 6.4.7.1. Market Size and Forecast, By Type
- 6.4.7.2. Market Size and Forecast, By Application
- 6.4.8. South Korea Alcohol Dehydrogenase Market
- 6.4.8.1. Market Size and Forecast, By Type
- 6.4.8.2. Market Size and Forecast, By Application
- 6.4.9. Australia Alcohol Dehydrogenase Market
- 6.4.9.1. Market Size and Forecast, By Type
- 6.4.9.2. Market Size and Forecast, By Application
- 6.4.10. Rest of Asia-Pacific Alcohol Dehydrogenase Market
- 6.4.10.1. Market Size and Forecast, By Type
- 6.4.10.2. Market Size and Forecast, By Application
- 6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Type
- 6.5.3. Market Size and Forecast, By Application
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Alcohol Dehydrogenase Market
- 6.5.5.1. Market Size and Forecast, By Type
- 6.5.5.2. Market Size and Forecast, By Application
- 6.5.6. South Africa Alcohol Dehydrogenase Market
- 6.5.6.1. Market Size and Forecast, By Type
- 6.5.6.2. Market Size and Forecast, By Application
- 6.5.7. Saudi Arabia Alcohol Dehydrogenase Market
- 6.5.7.1. Market Size and Forecast, By Type
- 6.5.7.2. Market Size and Forecast, By Application
- 6.5.8. Rest of LAMEA Alcohol Dehydrogenase Market
- 6.5.8.1. Market Size and Forecast, By Type
- 6.5.8.2. Market Size and Forecast, By Application
CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top Winning Strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
- 8.1. Sigma-Aldrich
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
- 8.2. Thermo Fisher Scientific
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
- 8.3. BioVision Inc.
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
- 8.4. Creative Enzymes Technologies, LLC
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
- 8.5. MP Biomedicals
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
- 8.6. Randox Laboratories Limited
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
- 8.7. Sekisui Diagnostics
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
- 8.8. Prospec-Tany Technogene Ltd.
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
- 8.9. Roche Diagnostics
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
- 8.10. Worthington Biochemical Corp.
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments
